Literature DB >> 20969626

Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.

Andresa Borges Soares1, Albina Altemani, Vera Cavalcanti de Araújo.   

Abstract

BACKGROUND: Recurrent pleomorphic adenoma (RPA) is an uncommon and challenging disease. The aim of this study was to review the clinical information obtained by examining RPA patients, to determine its histomorphological features and to verify the expression of the Mcm-2 markers of cell proliferation and the expression of p-53 in pleomorphic adenoma (PA), RPA, and RPA with malignant transformation (TRPA).
METHODS: A total of 10 cases of PA and 29 cases of RPA were examined in detail for the presence of nodules and their histomorphological features. Cell proliferation and expression of p-53 were detected by the immunohistochemical technique using the antibodies against Mcm-2 and p-53.
RESULTS: Histopathologically, RPA is very similar to PA; the only difference found was that all the cases of RPA were multinodular. When comparing primary and recurrent tumor, no significant difference was found in terms of cell proliferation and the expression of p-53; however, in the RPA with areas of malignant transformation there was an increased expression of these proteins.
CONCLUSION: This study showed that recurrences were multinodular, with nodules varying in numbers and sizes. No significant difference in histological features was found between RPA and PA. Moreover, the immunohistochemical study showed a low expression of p-53 and Mcm-2 in PA and RPA and an increased expression of these proteins in the RPA with areas of malignant transformation.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969626     DOI: 10.1111/j.1600-0714.2010.00956.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

2.  Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.

Authors:  Leorik Pereira Silva; Thalita Santana; Bruno Tavares Sedassari; Suzana Machado de Sousa; Ana Paula Veras Sobral; Roseana de Almeida Freitas; Carlos Augusto Galvão Barboza; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-18       Impact factor: 2.503

3.  Recurrent Pleomorphic Adenoma of the Submandibular Gland.

Authors:  Serhat İnan; Erdinç Aydın; Seda Türkoğlu Babakurban; Eda Yılmaz Akçay
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-03-01

4.  Pleomorphic adenomas of the salivary glands: retrospective multicentric study of 130 cases with emphasis on histopathological features.

Authors:  Maria Luiza Diniz de Sousa Lopes; Keila Martha Amorim Barroso; Águida Cristina Gomes Henriques; Jean Nunes Dos Santos; Manoela Domingues Martins; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-12       Impact factor: 2.503

5.  Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.

Authors:  Ana Amélia de Souza; Albina Altemani; Ney Soares de Araujo; Lucas Novaes Texeira; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Clin Pathol       Date:  2019-09-26

6.  Novel Technique for the Surgical Management of Pleomorphic Adenoma of the Upper Lip.

Authors:  Dyna Albert; Senthil Murugan Pandurangan; Purva Kulkarni; Santhosh P Kumar; Murugesan Krishnan; Twinkle Francis
Journal:  Cureus       Date:  2022-07-24

7.  Histomorphological comparison of pleomorphic adenoma in major and minor salivary glands of oral cavity: A comparative study.

Authors:  S Nonitha; T L Yogesh; S Nandaprasad; B Uma Maheshwari; I P Mahalakshmi; Bhavana T Veerabasavaiah
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.